Paroxetine, Panorama and user reporting of ADR's

Charles Medawar a,∗, Andrew Herxheimer b, Andrew Bell c and Shelley Jofre c


a Social Audit Ltd., London, UK

bDIPEx Project, Department of Primary Health Care, University of Oxford, Oxford, UK

c British Broadcasting Corporation (BBC), London, UK


http://www.motkur.no/paroxetine.pdf


Abstract. We systematically analysed two complementary samples of emails relating to patients’ problems with the popular SSRI antidepressant, paroxetine. These mainly concerned serious mood disorders and drug withdrawal symptoms. 1,374 emails were immediate responses to a major BBC-TV documentary programme. These were contrasted with 862 messages on similar themes sent to a website discussion forum over a period of nearly three years. Despite the limitations of most individual email reports, we judged their collective weight to be profound. We also suggest that the value of “immersion” in a large body of such
data may be greater than continuing exposure to a variable trickle of reports.We discuss the significance of these data in relation to the patient–prescriber relationship and pharmacovigilance. We suggest that the Internet offers unparalleled opportunities for soliciting and monitoring patients’ reports of adverse drug reactions, and propose practical initiatives to capture peoples’ experiences and thereby promote safer and more effective drug use.

read on - http://www.motkur.no/paroxetine.pdf